Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2026-01-01 @ 11:16 AM
Study NCT ID:
NCT06053658
Status:
RECRUITING
Last Update Posted:
2025-09-05
First Post:
2023-09-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-05
Start Date Type:
ACTUAL
Primary Completion Date:
2026-11-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-11-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-09-19
First Submit QC Date:
None
Study First Post Date:
2023-09-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-03
Last Update Post Date:
2025-09-05
Last Update Post Date Type:
ESTIMATED